Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2D6 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
SERTRALINE 59,788 6,889 11.5% 19,327 4,613 44.8 yrs 63.5%
IMATINIB 43,161 13,761 31.9% 7,264 1,050 55.7 yrs 47.2%
EVEROLIMUS 39,640 8,374 21.1% 11,211 1,311 53.4 yrs 60.0%
ABIRATERONE 34,511 7,180 20.8% 8,816 757 74.9 yrs 0.5%
AMIODARONE 25,143 3,845 15.3% 13,711 3,889 69.9 yrs 36.9%
NILOTINIB 23,171 4,543 19.6% 4,846 683 56.5 yrs 47.7%
PAZOPANIB 21,208 5,612 26.5% 4,347 572 61.2 yrs 41.2%
MIRABEGRON 20,618 1,338 6.5% 2,589 1,150 69.8 yrs 69.1%
RITONAVIR 11,980 1,190 9.9% 2,925 350 43.8 yrs 43.8%
CLOBAZAM 10,596 725 6.8% 3,312 553 29.3 yrs 49.1%

Head-to-Head Comparisons

SERTRALINE vs IMATINIB SERTRALINE vs EVEROLIMUS SERTRALINE vs ABIRATERONE SERTRALINE vs AMIODARONE IMATINIB vs EVEROLIMUS IMATINIB vs ABIRATERONE IMATINIB vs AMIODARONE EVEROLIMUS vs ABIRATERONE EVEROLIMUS vs AMIODARONE ABIRATERONE vs AMIODARONE
← Back to Cytochrome P450 2D6 Inhibitors [MoA] Class side effects →